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Abstract Neutrophils are the most abundant white blood
cells in humans and play a vital role in several aspects of
the immune response. Numerous reports have implicated
neutrophil glycosylation as an important factor in mediating
these interactions. We report here the application of high
sensitivity glycomics methodologies, including matrix
assisted laser desorption ionisation (MALDI-TOF) and
MALDI-TOF/TOF analyses, to the structural analysis of
N- and O-linked carbohydrates released from two samples
of neutrophils, prepared by two separate and geographically
remote laboratories. The data produced demonstrates that
the cells display a diverse range of sialylated and
fucosylated complex glycans, with a high level of similarity
between the two preparations.
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Abbreviations
PNGase F Peptide N-glycosidase F
MALDI Matrix assisted laser desorption ionisation
CAD Collision activated decomposition
Hex Hexose
HexNAc N-acetylhexosamine
ESL-1 E-selectin ligand-1
FAB Fast atom bombardment
Fuc Fucose
Gal Galactose
GalNAc N-acetylgalactosamine
Glc Glucose
GlcNAc N-acetylglucosamine
Man Mannose
NeuAc N-acetylneuraminic acid
MS Mass spectrometry
MS/MS Tandem mass spectrometry
PSGL-1 P-selectin glycoprotein ligand 1
TOF Time of flight
Le
x Lewis
x
Le
a Lewis
a
sLe
x Sialyl Lewis
x
sLe
a Sialyl Lewis
a
Introduction
Neutrophils are the most abundant white blood cells in
humans. During an acute inflammatory response, circulating
neutrophils interact with the activated endothelium through
receptor-mediated processes involving selectins and integrins.
Neutrophils interact with P-selectin, E-selectin and other
adhesion molecules on activated endothelial cells or captured
platelets to initiate leukocyte rolling and tethering [1–3]. This
promotes leukocyte activation and integrin-mediated adhe-
sion that allows activated neutrophils to migrate from the
circulation into the tissue space. Neutrophils are the first
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chemotaxis, internalising and killing microorganisms and
ingesting particles through the process of phagocytosis.
Defects in phagocytosis can lead to immunodeficiency
related diseases in children [4]. Decreased neutrophil
adherence and impaired chemotaxis have also been
associated with congenital recurrence infections [5–7].
The tethering of neutrophils is mediated by cell surface
carbohydrate ligands and selectins present on the endo-
thelial cells [8]. The structural characterization of cell
surface glycoconjugates from neutrophil granulocytes was
first addressed more than two decades ago using Fast
Atom Bombardment mass spectrometry (FAB-MS) com-
plemented by linkage analyses and exoglycosidase digests
[9]. This technology showed that the cell surface N-
glycans were highly fucosylated and sialylated and many
of their antenna were comprised of poly-N-acetyllactosa-
minyl backbones (-3Galβ1-4GlcNAcβ1-)n, often referred
to as polyLacNAc. Also identified was the sialyl Lewis
x
epitope (NeuAcα2–3Galβ1(Fucα1–3)4GlcNAc-R) which,
several years later, was shown to play a critical role in
selectin-mediated neutrophil trafficking [10–14].
FAB-MS technology was a powerful technique for
defining the structures of glycan determinants at the non-
reducing ends of the N-glycan antennae and for giving an
indication of the length of antennae. This information was
afforded by A-type fragment ions that were produced in the
source of the FAB mass spectrometer via cleavage at each
of the GlcNAc residues during the ionisation of permethy-
lated glycans [15]. The weakness of the FAB-MS experi-
ment was its poor sensitivity above m/z 3000 and the high
chemical noise background throughout the observable mass
range which made detection of minor components very
difficult. Thus, although the FAB-MS experiments of the
1980s revealed vitally important aspects of neutrophil
glycosylation, their characterisation of the neutrophil
glycome was far from comprehensive.
Recent advancements in mass spectrometric techniques
have had an enormous impact on the structural analysis of
complex glycan mixtures from cells and tissues and it is
therefore timely to reassess neutrophil glycosylation [16].
Probably the most significant mass spectrometric advance
has been the replacement of FAB-MS instrumentation by
MALDI-TOF and MALDI-TOF/TOF-MS. This has
enabled very significant increases in levels of sensitivity,
upper mass range and reduced levels of chemical noise
background. Most significantly the tandem MS/MS capa-
bility of MALDI-TOF/TOF instrumentation means that
individual glycan molecular ions, even at high m/z values,
can be fragmented to afford structurally informative
fragment ion data [17]. However a critical step still remains
the permethylation of glycans as this not only increases the
sensitivity of the analysis but also facilitates the unambiguous
sequencing of individual carbohydrate structures in MS/MS
experiments.
In this paper we document the structural analysis of N-
and O-glycans from resting human neutrophils using the
above described strategy. To establish sample-sample
consistency, two batches of cells were prepared by
geographically remote groups, one based in the UK and
one in the US. Permethylated N-glycans up to m/z 6500 in
mass were detected in derivatised PNGase F released
material, the largest intact N-glycans thus far directly
observed by MS in human samples. The sialyl Le
x
containing carbohydrate cell surface antigens present on
the neutrophils were character i z e db yh i g h - s e n s i t i v i t yM S /
MS techniques. We found that sialyl Le
x containing
glycans constitute less than 0.05% of the total N-glycans
observed, while approximately 5% of the O-glycan
structures contain sialyl Le
x as a terminal epitope. In
addition, the robust and reproducible nature of the
glycomic methodologies employed is highlighted by the
fact that variation between Sample 1 (US) and Sample 2
(UK) was minimal.
Materials and methods
Materials
All the reagents used in this study were of high purity
obtained from Sigma-Aldrich except as noted.
Mixed granulocyte preparation and isolation of neutrophils
Human neutrophils sample 1 (USA) were isolated in
accordance with a protocol approved by the OUHSC
Institutional Review Board. Neutrophils were isolated by
drawing 30 ml whole blood into a 60 ml syringe containing
100 U heparin, mixed with a 6% Dextran 70 in 0.9%
Sodium Chloride injection USP (Braun Medical Inc.) and
allowed to sediment for 30 min at RT. The leukocyte
fraction was then isolated, centrifuged and subjected to
hypotonic lysis to remove contaminating RBCs. Leuko-
cytes were then subjected to density gradient centrifugation
using Histopague-1077 (Sigma-Aldrich) followed by wash-
ing cells twice in HBSS using the procedure of Zimmerman
et al. 1985, [18]. Isolated cells were found to be >90%
neutrophils by Wright–Giemsa staining.
The isolation of human neutrophils from Sample 2 (UK)
was carried out according to a protocol approved by St.
Mary’s Hospital (London, UK). Neutrophils were isolated
by drawing 30 ml whole blood into a 60 ml syringe
containing 4.4 ml of 3.8% trisodium citrate (Citric Acid
Sigma Cat. No. C8532). The blood was centrifuged at
310 g for 20 min (no brake applied) and the top layer of
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erythrocytes and buffy coat were mixed with a 6%
Dextran® (GE Healthcare Cat. No. 17-0320-01) and
0.9% sterile Sodium Chloride was added up to 50 ml
a n da l l o w e dt os e d i m e n tf o r2 0m i na tR T .T h e
leukocyte fraction was then subjected to density gradient
centrifugation using Histopague-1077 (Sigma-Aldrich).
The remaining erythrocytes were lysed by hypotonic
lysis. Neutrophils were positively isolated from the
mixed granulocyte preparation using anti-CD16 microbeads
(50 μl of beads per 50×106 cells, Miltenyi Biotec Cat. No.
130-045-701) and Miltenyi LS columns. This yielded
neutrophils of 99% purity [19].
Reduction and carboxymethylation
Approximately 2×10
7 human neutrophil cells were sonicated
in extraction buffer (25 mM Tris, 150 mM NaCl, 5 mM
EDTA and 1% CHAPS at pH 7.4) and then dialysed against
4×4.5 l of 50 mM ammonium bicarbonate, pH 8.5, at 4°C
for 48 h (as described previously [20]). After dialysis, the
sample was lyophilized. The sample was then reduced in
1 ml of 50 mM Tris–HCl buffer, pH 8.5, containing 2 mg/ml
dithiothreitol. Reduction was performed under a nitrogen
atmosphere at 37°C for 1 h. Carboxymethylation was
carried out by the addition of iodoacetic acid (five-fold
molar excess over dithiothreitol), and the reaction was
allowed to proceed under a nitrogen atmosphere at room
temperature in the dark for 2 h. Carboxymethylation was
terminated by dialysis against 4×4.5 l of 50 mM ammo-
nium bicarbonate, pH 8.5, at 4°C for 48 h. After dialysis,
the sample was lyophilized.
Tryptic digest
The reduced carboxymethylated proteins were digested
with TPCK pre-treated bovine pancreas trypsin (EC
3.4.21.4, Sigma), for 16 h at 37°C in 50 mM ammonium
bicarbonate buffer (pH 8.4). The products were purified by
C18-Sep-Pak (Waters Corp.) as described [21].
Sep-Pak® separation of released glycans from peptides
The reverse-phase C18 Sep-Pak cartridge was primed
sequentially with 5 ml methanol, 5 ml 5% acetic acid (v/v)
and 5 ml propan-1-ol before being re-equilibrated with 10 ml
5% acetic acid (v/v). The sample was then dissolved in a
minimum volume of 5% acetic acid (v/v) and loaded directly
onto the Sep-Pak. Elution was achieved using 3 ml of 5%
acetic acid (v/v), followed by 2 ml each of 20%, 40%, 60%
and 100% propan-1-ol in 5% acetic acid (v/v). Each elution
step was collected, reduced in volume on a Speed Vac and
lyophilised [21].
PNGase F digestion of glycopeptides
PNGase F (EC3.5.1.52, Roche Molecular Biochemicals,
Lewes, UK) digestion was carried out in 200 μl ammonium
bicarbonate (50 mM, pH 8.5) for 16 h at 37°C using 3 U of
enzyme. The reaction was terminated by lyophilization and
the released N-glycans were separated from peptides and O-
glycopeptides by Sep-Pak C18 (Waters, Elstree, UK) as
described [22].
Sep-Pak® separation of permethylated glycans
The reverse-phase C18 Sep-Pak cartridge was primed
sequentially with 5 ml methanol, 5 ml water and 5 ml
acetonitrile before being re-equilibrated with 10 ml of
water. The lyophilised permethylated oligosaccharide sam-
ple was then dissolved in a minimum volume of methanol
and loaded directly onto the Sep-Pak. Elution was achieved
using 3 ml of water followed by 2 ml each of 15%, 30%,
50%, 75% and 100% acetonitrile in water (v/v). Each
elution step was collected, reduced in volume on a Speed
Vac and lyophilised [22].
Reductive elimination
O-glycans were released by reductive elimination in
400 μL of 0.1 M potassium borohydride (54 mg/ml of
potassium hydroxide in water) solution at 45°C for 16 h.
The reaction was terminated by dropwise addition of glacial
acetic acid, followed by Dowex 50W-X8 (H) 50–100 mesh
(Sigma) chromatography and borate removal.
Neuraminidase treatment
A portion of the underivatised N-glycan was dissolved in
100 μl pH 5.5 50 mM ammonium acetate buffer and incubated
at 37°C with 50 U of Vibrio cholerae neuraminidase (EC No.
3.2.1.18). After 18 h the sample was lyophilized and then
permethylated before MALDI-TOF analysis.
Derivatisation for MALDI-TOF and tandem mass
spectrometry analysis
Permethylation was performed using the sodium hydroxide
procedure, as described previously [22]. 1 g of sodium
hydroxide pellets were crushed in a glass mortar with 3 ml
distilled, anhydrous DMSO. 1 ml of the resulting slurry and
200 μl of methyl iodide were added to the lyophilised
sample. The mixture was then shaken for 10 min before the
reaction was quenched by dropwise addition of water. The
permethylated sample was then extracted into 1 ml of
chloroform and washed with 4×1 ml of water. The
chloroform was then removed under a stream of nitrogen.
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MALDI-TOFdatawereacquired ona Voyager-DE STR mass
spectrometer (Applied Biosystems, Foster City, CA) in the
reflectron mode with delayed extraction. Permethylated
samples were dissolved in 10 μlo fm e t h a n o la n d1μlo f
dissolvedsamplewaspremixedwith1 μlofmatrix(20mg/ml
2,5-dihydroxybenzoic acid (DHB) in 70% (v/v) aqueous
methanol),spottedontoatargetplateanddriedundervacuum.
Peaks observed in the MS spectra were selected for
further MS/MS. MS/MS data were acquired using a 4800
MALDI TOF/TOF (Applied Biosystems) mass spectrometer.
The potential difference between the source acceleration
voltage and the collision cell was set to 1 kVand argon was
used as collision gas. The 4700 Calibration Standard kit,
calmix (Applied Biosystems), was used as the external
calibrant for the MS mode and [Glu1] fibrinopeptide B
human (Sigma-Aldrich) was used as an external calibrant for
the MS/MS mode.
Automated MS and MS/MS analysis
Annotation of the MS and MS/MS data was achieved with
assistance from the Cartoonist algorithm [23]a n dt h e
GlycoWorkbench software suite [24].
Results
Employed strategy
In this communication we report the N- and O-glycan
profiles from human neutrophils using mass spectrometry.
Cell preparations from the Cummings (Sample 1 (US)) and
the Rankin (Sample 2 (UK)) laboratories were sonicated,
reduced/carboxymethylated and digested with trypsin. The
preparation of tryptic glycopeptides facilitates the release of
N- and O-glycans by PNGase F and reductive elimination,
respectively. Purified glycans were permethylated to enhance
the sensitivity of detection and to direct the subsequent MS/
MS fragmentation.
MALDI-MS was employed to obtain a profile of the
molecular ions giving singly charged sodiated molecular
ions[M+Na]
+. Although not fully quantitative, recent studies
have demonstrated that relative quantitation based on
signal intensities of permethylated glycans analyzed by
MALDI-TOF MS is a reliable method, especially when
comparing signals over a small mass range within the same
spectrum [17]. Molecular ions observed in the MS spectrum
were subjected to MS/MS analysis, which afforded
sequence informative fragment ions that provided vital
structural information such as the non-reducing end se-
quences i.e. antennae structures, branching patterns and
sometimes linkage positions. The assignments of neutrophil
N-glycan spectra were carried out with the assistance of
Cartoonist [23], a bespoke algorithm designed to mimic
the human approach to the analysis and assignment of N-
glycan MALDI spectra. Cartoonist searches the raw MS
data for peak envelopes and uses knowledge of the
biosynthetic pathways in order to present the user with
the most likely permethylated carbohydrate structures for
each signal. MS/MS spectra were assigned with the support
of the GlycoWorkbench suite [24] of software tools, which
are designed to assist the experts during the annotation of
glycan fragment spectra. The graphical interface of Glyco-
Workbench provides an environment in which structure
models can be rapidly assembled, automatically matched
with MS
n data and compared to assess the best candidate.
MALDI-TOF analysis of released N-glycans from human
neutrophils
Samples of human neutrophil cells from the two geograph-
ically remote sources (see “Materials and methods”) were
subjected to glycan profiling by MALDI-TOF MS analysis.
The mass spectra of the PNGase F released glycans (Fig. 1
and Table 1) were exceptionally rich in molecular ion
signals, corresponding to [M +Na]
+ adducts up to m/z 6500.
A relatively small amount of the sample (less than 5%) was
represented by the high mannose type structures (observed
at m/z 1580.2, 1784.2, 1988.2, 2192.2 and 2396.1), with the
vast majority of observed signals being consistent with
complex type glycans, comprising of bi-, tri-, and tetra-
antennary structures, capped with one, two, three or four
sialic acid residues. There was a high degree of fucosylation
amongst the complex glycans, with structures consistent
with both Le
x/a and sialyl Le
x/a antennae, as well as
prevalent polyLacNAc extensions (m/z 2401.1–6528.1,
Table 1). Previous detailed evidence from our neutrophil
studies categorically established that the antennae are Le
x
and sialyl Le
x rather than Le
a and sialyl Le
a [9].
MALDI-TOF/TOF analysis of released N-glycans
from human neutrophils
Collision-activated decomposition (CAD) MALDI-TOF/
TOF MS/MS experiments were carried out upon molecular
ions observed in the MALDI spectrum, yielding fragment
ions that defined structural features including core fucosy-
lation, antennal LacNAc extensions, Le
x and sialyl Le
x
epitopes. These experiments were carried out on both
neutrophil samples, and returned highly consistent results.
Data representative of these experiments is shown in Fig. 2
(m/z 3141.1 and m/z 3766.6).
The most prominent peak in each sample is that of a bi-
antennary, mono-sialylated, di-fucosylated structure of the
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Fig. 1 M A L D I - T O FM Sp r o f i l e so ft h ep e rmethylated N-linked glycans
from human neutrophils. Major peaks are annotated with the relevant
carbohydrate structure shown in symbol form, according to the glycan
nomenclature adopted by the CFG (http://www.functionalglycomics.org/).
Neutrophil Sample 1 (US) is displayed in panels (a), (b) and (c).
Neutrophil Sample 2 (UK) is displayed in panels (d), (e) and (f). For
complete annotation of the spectra see Table 1. All molecular ions are
present in sodiated form ([M +Na]
+)
Glycoconj J (2009) 26:975–986 979empirical composition NeuAc1Fuc2Hex5HexNAc4 (m/z
2779.0). Despite being a potential sialyl Le
x structure,
MSMS analysis demonstrates that all detectable isomers
represented by the peak in fact carry the antennal fucose on
the non-sialylated arm (Fig. 2a). This is a theme that
persists through the N- and O-glycan samples, highlighting
the apparent paucity of sialyl Le
x amongst the neutrophil
glycans. As exemplified by this component, whenever there
is an option to sialylate and fucosylate separate antenna
rather than place both substituents on a single antenna, the
Table 1 Compositional assignments of singly charged sodiated
molecular ions, [M +Na]
+, observed in MALDI-MS spectra of
permethylated N-glycans from human neutrophils
Signal (m/z)
Sample 1 (US)
Signal (m/z)
Sample 2 (UK)
Molecular Assignments
1580.2 1579.9 Hex5HexNAc2
1591.2 1591.0 Fuc1Hex3HexNAc3
1765.2 1765.0 Fuc2Hex3HexNAc3
1784.2 1784.0 Hex6HexNAc2
1795.2 1795.0 Fuc1Hex4HexNAc3
1836.2 – Fuc1Hex3HexNAc4
1952.2 1952.1 NeuAc1Fuc1Hex3HexNAc3
1969.2 1969.1 Fuc2Hex4HexNAc3
1988.2 1988.1 Hex7HexNAc2
2040.1 2040.2 Fuc1Hex4HexNAc4
2082.1 2081.1 Fuc1Hex3HexNAc5
2156.1 2156.2 NeuAc1Fuc1Hex4HexNAc3
2192.2 2192.2 Hex8HexNAc2
2244.1 2244.3 Fuc1Hex5HexNAc4
2396.1 2396.3 Hex9HexNAc2
2401.1 2401.3 NeuAc1Fuc1Hex4HexNAc4
2418.1 2418.4 Fuc2Hex5HexNAc4
2431.1 2431.3 NeuAc1Hex5HexNAc4
2592.1 2592.4 Fuc3Hex5HexNAc4
2605.0 2605.4 NeuAc1Fuc1Hex5HexNAc4
2693.1 2693.5 Fuc1Hex6HexNAc5
2779.0 2779.5 NeuAc1Fuc2Hex5HexNAc4
2867.0 2867.6 Fuc2Hex6HexNAc5
2965.9 2966.6 NeuAc2Fuc1Hex5HexNAc4
3040.9 3041.7 Fuc3Hex6HexNAc5
3053.9 3054.7 NeuAc1Fuc1Hex6HexNAc5
3139.8 3140.7 NeuAc2Fuc2Hex5HexNAc4
3227.9 3228.8 NeuAc1Fuc2Hex6HexNAc5
3315.8 3316.8 Fuc2Hex7HexNAc6
3401.8 3402.8 NeuAc1Fuc3Hex6HexNAc5
3414.8 3415.8 NeuAc2Fuc1Hex6HexNAc5
3502.8 3503.9 NeuAc1Fuc1Hex7HexNAc6
3588.8 3589.9 NeuAc2Fuc2Hex6HexNAc5
3676.8 3678.0 NeuAc1Fuc2Hex7HexNAc6
3775.7 3777.0 NeuAc3Fuc1Hex6HexNAc5
3850.7 3852.1 NeuAc1Fuc3Hex7HexNAc6
3863.6 3865.0 NeuAc2Fuc1Hex7HexNAc6
3951.6 3953.1 NeuAc1Fuc1Hex8HexNAc7
4024.6 4026.2 NeuAc1Fuc4Hex7HexNAc6
4037.6 4039.1 NeuAc2Fuc2Hex7HexNAc6
4125.6 4127.2 NeuAc1Fuc2Hex8HexNAc7
4211.5 4213.2 NeuAc2Fuc3Hex7HexNAc6
4224.6 4226.2 NeuAc3Fuc1Hex7HexNAc6
4299.5 4301.3 NeuAc1Fuc3Hex8HexNAc7
4312.5 4314.3 NeuAc2Fuc1Hex8HexNAc7
4400.4 4402.3 NeuAc1Fuc1Hex9HexNAc8
4473.4 4475.4 NeuAc1Fuc4Hex8HexNAc7
4486.5 4488.3 NeuAc2Fuc2Hex8HexNAc7
4574.4 4576.4 NeuAc1Fuc2Hex9HexNAc8
4660.4 4662.4 NeuAc2Fuc3Hex8HexNAc7
4674.4 4675.4 NeuAc3Fuc1Hex8HexNAc7
4748.4 4750.5 NeuAc1Fuc3Hex9HexNAc8
4761.4 4763.5 NeuAc2Fuc1Hex9HexNAc8
Table 1 (continued)
Signal (m/z)
Sample 1 (US)
Signal (m/z)
Sample 2 (UK)
Molecular Assignments
4834.3 4836.6 NeuAc2Fuc4Hex8HexNAc7
4848.3 4850.5 NeuAc1Fuc1Hex10HexNAc9
4922.1 4924.6 NeuAc1Fuc4Hex9HexNAc8
4935.3 4937.6 NeuAc2Fuc2Hex9HexNAc8
5023.3 5024.6 NeuAc1Fuc2Hex10HexNAc9
5035.3 – NeuAc4Fuc1Hex8HexNAc7
5096.3 5098.7 NeuAc1Fuc5Hex9HexNAc8
5109.3 5111.7 NeuAc2Fuc3Hex9HexNAc8
5122.3 5125.7 NeuAc3Fuc1Hex9HexNAc8
5197.2 5199.7 NeuAc1Fuc3Hex10HexNAc9
5210.3 5212.6 NeuAc2Fuc1Hex10HexNAc9
5270.3 5272.6 NeuAc1Fuc6Hex9HexNAc8
5283.2 5285.8 NeuAc2Fuc4Hex9HexNAc8
5296.1 5299.7 NeuAc3Fuc2Hex9HexNAc8
5371.1 5373.7 NeuAc1Fuc4Hex10HexNAc9
5384.1 5386.8 NeuAc2Fuc2Hex10HexNAc9
5458.2 5459.8 NeuAc2Fuc5Hex9HexNAc8
5471.1 5472.8 NeuAc3Fuc3Hex9HexNAc8
5484.1 5486.8 NeuAc4Fuc1Hex9HexNAc8
5546.0 5547.9 NeuAc1Fuc5Hex10HexNAc9
5559.1 5560.9 NeuAc2Fuc3Hex10HexNAc9
5572.1 5573.8 NeuAc3Fuc1Hex10HexNAc9
5644.9 5647.9 NeuAc3Fuc4Hex9HexNAc8
5657.9 5660.9 NeuAc4Fuc2Hex9HexNAc8
5720.0 5721.7 NeuAc1Fuc6Hex10HexNAc9
5733.0 5734.0 NeuAc2Fuc4Hex10HexNAc9
5745.9 5748.1 NeuAc3Fuc2Hex10HexNAc9
5819.9 5821.1 NeuAc3Fuc5Hex9HexNAc8
5832.9 5834.5 NeuAc4Fuc3Hex9HexNAc8
5906.9 5909.5 NeuAc2Fuc5Hex10HexNAc9
5919.9 5922.9 NeuAc3Fuc3Hex10HexNAc9
5993.7 5996.0 NeuAc3Fuc6Hex9HexNAc8
6007.1 – NeuAc4Fuc4Hex9HexNAc8
6079.9 – NeuAc2Fuc6Hex10HexNAc9
6092.7 – NeuAc3Fuc4Hex10HexNAc9
6107.8 – NeuAc4Fuc2Hex10HexNAc9
6168.8 – NeuAc3Fuc7Hex9HexNAc8
6181.7 – NeuAc4Fuc5Hex9HexNAc8
6281.6 – NeuAc4Fuc3Hex10HexNAc9
6354.6 – NeuAc4Fuc6Hex9HexNAc8
6456.2 – NeuAc4Fuc4Hex10HexNAc9
6528.1 – NeuAc4Fuc7Hex9HexNAc8
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Ac1Fuc2Hex5HexNAc4 being consistent with components
carrying a sialyl Le
x antennae, none were observed. Instead
the NeuAc is located on an unsubstituted antenna as shown
by fragment ions at m/z 1751.0, 1955.1 and 847.4, while
the fucose residues are present on the chitobiose core (m/z
474.1) and on Le
x antennae (m/z 660.3, 2142.2 and
1767.9).
The MS/MS analysis of the signals centred at m/z 3141.0
(Fig. 2b), initially assigned as NeuAc2Fuc2Hex5HexNAc4,
revealed an additional composition, namely Fuc1Hex7Hex-
NAc6 which is only two mass units heavier than Neu-
Ac2Fuc2Hex5HexNAc4 and therefore the isotopic clusters
overlap. The base peak of the spectrum at m/z 2766.8
represents the loss of NeuAc from the sialylated compo-
nent. The signals at m/z 474.2 (reducing end fucosylated
HexNAc) and m/z 1317.7 [FucHex3HexNAc2] are indica-
tive of core fucosylation, while peaks at m/z 1021.5 and
2141.2 establish the presence of a sialyl Le
x antennae.
Signals at m/z 847.4 and 2316.4 confirm that one of the
antennae does not carry a fucose. Confirmation of the bi-
and/or tri-antennary nature of the non-sialylated constitu-
ents (as opposed to a tetra-antennary form of the same
composition) comes from ions observed at m/z 935.4 and
2230.5, representing loss of a single antenna consisting of
Hex2HexNAc2. LacNAc extensions are also sequentially
lost, as demonstrated by signals at m/z 2680.3 and 2216.2.
PolyLacNAc containing N-glycans
In order to obtain further structural information on the relative
abundance of glycans having the same empirical formula but
varying antennae structures, a portion of the underivatised N-
glycan mixture was digested with a broad spectrum Vibrio
cholerae neuraminidase. The resulting sample was permethy-
lated and analysed by MS and MS/MS methods. The MS
spectrum of the desialylated N-glycans showed a smaller
number of molecular ion signals which were better resolved
as compared to the native spectrum because the desialylated
sample no longer contained compositions that were closely
similarinmass(Fig.3 and Table 2). We were able to capitalise
on the reduced complexity, coupled with the concomitant
higher abundance of many of the molecular ions to inves-
tigate branching arrangements of the polyLacNAc-containing
components. For example, the MS/MS spectrum of the
molecular ion [M +Na]
+ m/z 3765, which has an empirical
composition of Fuc2Hex7HexNAc8, contained a series of
fragment ions carrying information on antennae length, in
addition to the most abundant fragment ion (m/z 3302.8)
which arises from loss of a non-reducing LacNAc (Fig. 4).
The fragment ions m/z 2230.3 and 2404.3 confirm the
presence of bi-antennary structures with a maximum of three
LacNAc units, with and without fucose on the antenna.
Signals are observed corresponding to loss of a single Le
x
moiety (m/z 3127.5) from the non-reducing end of an antenna,
as well as signals consistent with the loss of longer portions
from a single antenna—Le
x-LacNAc (m/z 2678.3) and Le
x-
LacNAc-LacNAc (m/z 2230.3). Evidence demonstrating the
presence of non-fucosylated antennae is present in the form of
signals representing the loss from the non-reducing end of a
single antenna of one LacNAc (m/z 3302.8), two LacNAc’s
connected in series (m/z 2854.2) and three sequential LacNAc
structures (m/z 2404). Cleavages across multiple antennae are
also observed, providing valuable insights into the arrange-
ments of the structural isomers present. The loss of a LacNAc
and a Le
x from separate antennae is observed at m/z 2664.6,
with a related signal showing the loss of a LacNAc from one
arm and a Le
x-LacNAc from another seen at m/z 2216.3.
There are also signals indicating the presence, at low levels, of
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Fig. 2 MALDI-TOF/TOF mass spectrum of the [M +Na]
+ molecular
ion m/z 3766.9 (composition Fuc2Hex8HexNAc9, Panel (a)) and m/z
3141.0 (compositions NeuAc2Fuc2Hex5HexNAc4 and Fuc1Hex7Hex-
NAc6, Panel (b)). Both spectra are derived from the permethylated N-
glycans released with PNGase F from neutrophil Sample 2 (UK)
(Fig. 1d and e). Assignments of the fragment ions are labelled
Glycoconj J (2009) 26:975–986 981at least two tri-antennary isomers, with the loss of three
separate non-reducing end LacNAc’s being observed at m/z
2376 and the loss of two LacNAc antennae plus a Le
x
antennal epitope seen at m/z 2202.3.
MALDI-TOF analysis of released O-glycans from human
neutrophils
O-glycans were chemically released by reductive elimina-
tion and their permethyl derivatives were analysed by
MALDI-TOF MS. The O-glycan profile (Fig. 5 and Table 3)
demonstrates that the most abundant glycan species is a
fucosylated core-2 glycan (m/z 1157.8). There is extensive
sialylation among the larger structures present, with
disialylated core 1 glycans being observed (m/z 1256.8)
alongside the more prevalent mono- and di-sialylated core 2
structures (m/z 1344.9 and 1706.1). The higher mass
regions contain fucosylated signals consistent with Le
x
and sialyl Le
x epitopes (m/z 2142.4) as well as polyLacNAc
extensions (m/z 2329.4).
MALDI-TOF/TOF analysis of released O-glycans
from human neutrophils
Exemplar data from these experiments are shown in Fig. 6.
In similar fashion to the N-glycans, MSMS analysis was
consistent across the two geographically remote sample
Table 2 Compositional assignments of singly charged sodiated
molecular ions, [M+ Na]
+, observed in MALDI-MS spectra of
permethylated N-glycans after neuraminidase digestion
Signal m/z Molecular Assignments
1580.2 Hex5HexNAc2
1784.3 Hex6HexNAc2
1988.4 Hex7HexNAc2
2192.6 Hex8HexNAc2
2244.6 Fuc1Hex5HexNAc4
2396.7 Hex9HexNAc2
2418.7 Fuc2Hex5HexNAc4
2600.8 Hex10HexNAc2
2693.9 Fuc1Hex6HexNAc5
2868.0 Fuc2Hex6HexNAc5
3042.1 Fuc1Hex6HexNAc5
3143.2 Fuc1Hex7HexNAc6
3317.3 Fuc2Hex7HexNAc6
3491.4 Fuc3Hex7HexNAc6
3592.5 Fuc1Hex8HexNAc7
3665.5 Fuc4Hex7HexNAc6
3766.6 Fuc2Hex8HexNAc7
3940.7 Fuc3Hex8HexNAc7
4041.8 Fuc1Hex9HexNAc8
4114.8 Fuc4Hex8HexNAc7
4215.9 Fuc2Hex9HexNAc8
4288.9 Fuc5Hex8HexNAc7
4390.0 Fuc3Hex9HexNAc8
4491.0 Fuc1Hex10HexNAc9
4564.1 Fuc4Hex9HexNAc8
4665.1 Fuc2Hex10HexNAc9
4738.2 Fuc5Hex9HexNAc8
4840.2 Fuc3Hex10HexNAc9
4912.2 Fuc6Hex9HexNAc8
4940.2 Fuc1Hex11HexNAc10
5014.3 Fuc3Hex10HexNAc9
5115.3 Fuc2Hex11HexNAc10
5187.4 Fuc4Hex10HexNAc9
5288.7 Fuc3Hex11HexNAc10
5364.4 Fuc5Hex10HexNAc9
5465.2 Fuc4Hex11HexNAc10
5564.3 Fuc2Hex12HexNAc11
5636.5 Fuc5Hex11HexNAc10
5737.4 Fuc3Hex12HexNAc11
5914.6 Fuc4Hex12HexNAc11
6013.7 Fuc2Hex13HexNAc12
6085.8 Fuc4Hex12HexNAc11
6187.9 Fuc3Hex13HexNAc12
6361.3 Fuc4Hex13HexNAc12
6461.5 Fuc2Hex14HexNAc13
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Fig. 3 MALDI-TOF profile of permethylated N-glycans after
neuraminidase digestion. Panel (a) shows the lower mass region and
panel (b) shows the higher mass region. All molecular ions are present
in sodiated form ([M +Na]
+)
982 Glycoconj J (2009) 26:975–986sets. The analysis of the molecular ion at m/z 1518.0
demonstrates that this is a core-2 O-glycan and in accord
with the N-glycans, sialylation and fucosylation occur on
separate antennae. Thus, there is no evidence of a sialyl Le
x
containing structural isomer, and instead the NeuAc is
located on the 3′-arm of the core-2 structure as shown by
fragment ions at m/z 620.3 and 921.5, while the fucose
residue is present on the 6′-arm of the core-2 in the context
of a Le
x structure (m/z 472.2, 660.3 and 881.4).
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Fig. 5 MALDI-TOF MS profiles of the permethylated O-linked glycans
from human neutrophils. Major peaks are annotated with the relevant
carbohydrate structure shown in symbol form, according to the glycan
nomenclature adopted by the CFG (http://www.functionalglycomics.org/).
Neutrophil Sample 1 (US) is displayed in panel a), while neutrophil
Sample 2 (UK) is displayed in panel (b)
Table 3 Compositional assignments of singly charged sodiated
molecular ions, [M +Na]
+, observed in MALDI-MS spectra of
permethylated O-glycans from human neutrophils
Signal (m/z)
Sample 1 (US)
Signal (m/z)
Sample 2 (UK)
Molecular Assignments
534.5 – Hex1HexNAc1-itol
– 779.4 Hex1HexNAc2-itol
895.6 895.4 NeuAc1Hex1HexNAc1-itol
983.7 983.4 Hex2HexNAc2-itol
1157.8 1157.5 Fuc1Hex2HexNAc2-itol
1256.8 1256.6 NeuAc2Hex1HexNAc1-itol
1344.9 1344.6 NeuAc1Hex2HexNAc2-itol
1433.0 1432.7 Hex3HexNAc3-itol
1519.0 1518.7 NeuAc1Fuc1Hex2HexNAc2-itol
1607.1 1606.7 Fuc1Hex3HexNAc3-itol
1706.1 1705.8 NeuAc2Hex2HexNAc2-itol
1794.2 1793.8 NeuAc1Hex3HexNAc3-itol
1880.2 1879.8 NeuAc2Fuc1Hex2HexNAc2-itol
1968.3 1967.9 NeuAc1Fuc1Hex3HexNAc3-itol
2142.4 2141.9 NeuAc1Fuc2Hex3HexNAc3-itol
2155.4 2154.9 NeuAc2Hex3HexNAc3-itol
2329.4 2329.0 NeuAc2Fuc1Hex3HexNAc3-itol
2417.5 2417.1 NeuAc1Fuc1Hex4HexNAc4-itol
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Fig. 6 MALDI-TOF/TOF mass spectrum of the [M +Na]
+ molecular
ion m/z 1518.0 derived from the permethylated O-glycans of
neutrophil Sample 2 (UK). Assignments of the fragment ions are
labelled
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Fig. 4 MALDI-TOF/TOF mass spectrum of the [M +Na]
+ molecular ion
m/z 3765 (composition Fuc2Hex8HexNAc9), derived from the neuramin-
idase treated permethylated N-glycans from neutrophil Sample 2 (UK)
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The results presented herein on the structural analyses of N-
and O-glycans from resting neutrophils exemplify the rapid
and very high sensitive detection capabilities of MALDI-
TOF/TOF mass spectrometry based glycomics methodology.
They clearly demonstrate the mass spectrometric analytical
advancements that have been made in upper mass range,
resolution, sensitivity and signal to noise ratios in compar-
ison to previous FAB-MS analyses [14]. The initial screening
of N-glycans from neutrophils using MALDI-TOF MS
revealed the following characteristics; i) high mannose type
structures Man5GlcNAc2 to Man9GlcNAc2 are present in
relatively minor quantities, ii) complex N-glycan structures
of mass up to m/z 6500 have been observed with the m/z
2779 peak being most abundant, iii) the majority of the
glycans are core fucosylated, iv) di-, tri- and tetra-antennary
structures with polyLacNAc (3Galβ1–4GlcNAc) structures
are present, v) an unusually high degree of truncated
structures are observed with the signal at m/z 2156 being
the second most abundant glycan (see Fig. 1). Consistent
with earlier work [9] our glycomics study showed that sialyl
Le
x,L e
x and polyLacNAc epitopes are terminal groups
decorating the N-glycans in neutrophils. The abundance of
sialyl Le
x-containing structures was substantially lower
compared to the Le
x terminated structures. The glycome
profile of the O-glycans consists of both core 1 and core 2
oligosaccharides with sialyl Le
x and Le
x as terminal
epitopes. A similar trend is observed for the ratio of sialyl
Le
x and Le
x containing structures to that of the N-glycans. In
addition, the variation in the data between the two cell
preparations was minimal, further reinforcing the findings of
the 2007 HUPO study where the MALDI-MS analysis of
permethylated N-glycans from transferrin and IgG were
shown to be highly sensitive and reproducible [17].
The low abundance of sialyl Le
x containing structures
observed in both N- and O-glycans suggests that the
availability and display of the active selectin ligands is
likely to be restricted to a few glycoproteins on the surface
of resting leukocytes. A large body of evidence suggests
that both P- and E-selectins bind to distinct sites on P-
selectin glycoprotein ligand-1 (PSGL-1), which is a
relatively low-abundance glycoprotein on the cell surface
[14]. Furthermore, O-glycans mainly contribute to PSGL-1
binding to P-selectins, whereas E-selectin binding has been
associated with sialylated fucosyl N-glycans present on E-
selectin ligand-1 (ESL-1) [25–28]. Interestingly, only a
minor portion of N- and O-glycans in PSGL-1 have been
suggested to be involved in selectin binding by radio
labelled glycan analysis [29–31]. In addition, sialyl Le
x
containing glycans present on PSGL-1 have also been
implicated in the aggregation of neutrophils by binding with
L-selectins present on the other neutrophils at the inflamma-
tion site [32]. These studies demonstrate that preferential
binding of selective sialyl Le
x receptors to different selectin
molecules has many biological implications.
Careful analyses of the isotopic distribution pattern of
each of the peaks present in the entire N-glycan MS
spectrum, especially the minor components, showed the
presence of more than one instance of overlapping of
signals. For example, the peak m/z 3141 consists of two
glycans of m/z 3141 and 3143 in a ratio of approximately
1:1 (Fig. 2b). The collision activated decomposition (CAD)
MS/MS analysis of this peak revealed that indeed the
presence of sialyl Le
x containing core fucosylated bi-
antennary glycan (m/z 3141.0) and a mixture of LacNAc
terminated bi- and tri-antennary glycans (m/z 3143.0). The
exoglycosidase assay also supported the finding by MS/MS
analysis, in which the peak m/z 3141.0 disappeared but not
m/z 3143.0 after treatment with broad spectrum neuramin-
idase. More interestingly, the percentage abundance of this
peak in whole of the neutrophil N-glycans is about 0.008%.
These results profoundly demonstrated the power and very
high sensitivity of glycomics methodology based on mass
spectrometric analysis.
After neuraminidase treatment the N-glycan signals
become more spread out facilitating MS/MS analyses of
glycans up m/z 6000. This enzymatic degradation allowed
us to readily explore the branching patterns of mixtures of
isobaric glycans by tandem mass spectrometry. For exam-
ple, TOF/TOF analysis of the permethylated glycan of mass
m/z 3766 showed that it mainly consists of more than one
isoform of a bi-antennary glycan with terminal polyLac-
NAc and Le
x structures (Fig. 4). No significant levels of tri-
or tetra-antennary structures were observed in this peak.
These studies involving enzymology and mass spectral data
analysis again demonstrate that the current glycomics
methodology can very effectively be used to obtain detailed
structural information about specific complex glycans from
within a large pool closely related structures.
ThepolyLacNAcglycansofthetypesthatwehaveobserved
on neutrophils have been shown to bind to a variety of galectins
[33–35]. However, binding of galectin-1 and galectin-3 with
neutrophil polyLacNAc ligands exhibit contrasting functions.
For example, the galectin-1 binding inhibits chemotaxis and
extravasation where as the galectin-3 enhances both of these
functions [36–38]. In addition, galectin-1 and galectin-3
induce phosphatidylserine exposure in human neutrophils
without apoptosis, but galectin-3, but not galectin-1, induces
apoptosis of activated T cells [39]. Diversity of sialylated
fucosyl polyLacNAc glycans present on the neutrophils
supports the hypothesis that different glycans bind to different
glycan receptors leading to manifestation of fundamentally
different biological functions [33].
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